FindTrial
Sign In

Study on Holo Lung Detox Tablets for Protecting Lung Health in Smokers

A Clinical study to evaluate the efficacy of Holo Lung Detox tablets in smokers as preventive therapy for healthy lungs - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/11/097491
Enrollment
50
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J705- Respiratory conditions due to smoke inhalation

Interventions

None listed

Sponsors

ZEROHARM Science Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects smoking a minimum of 5 cigarettes daily for atleast 3 years and showing a high level of alveolar CO levels. Subject with abnormal lung finding in Chest X-ray with P/A vie Subjects not suffering from any significant illness (medical / surgical) Subjects willing to follow the procedures as per the study protocol and voluntarily sign an informed consent form.

Exclusion criteria

Exclusion criteria: Patients suffering from acute infections. Pregnant or Lactating females

Design outcomes

Primary

MeasureTime frame
Assessment of cessation of smoking (reduction or complete giving up) To assess changes in Lung capacity by using spirometryTimepoint: 3 months—

Secondary

MeasureTime frame
Monthly assessment lung capacity measured by a Spirometer Assessment of quality of life on WHO QOL QuestionnaireTimepoint: 3 months—

Countries

India

Contacts

Public ContactDr Biswajit Das

Govt. Ayurvedic College, Jalukbari, Guwahati-14 Assam

drbiswa.das@rediffmail.com9127056217

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026